Pinealon (Glu-Asp-Arg) is a synthetic tripeptide bioregulator developed by Vladimir Khavinson’s group at the Saint Petersburg Institute of Bioregulation and Gerontology. It is classified as a “peptide bioregulator” — a short peptide that regulates gene expression related to its tissue of origin.
Pineal Gland Connection
Pinealon is designed to mimic the regulatory peptides naturally produced by the pineal gland. Research has examined its effects on melatonin synthesis, circadian rhythm regulation, and antioxidant enzyme expression in neural tissue models.
Gene Regulation
Short peptide bioregulators like pinealon are hypothesized to interact with DNA through sequence-specific binding, particularly in the minor groove. The EDR (Glu-Asp-Arg) sequence has been studied for its potential to modulate the expression of genes involved in neuroprotection and apoptosis regulation.